REBECCA DAVIS: Open Payments
NPI 1285904052 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 19 payments from 9 companies in 2025. Trend: 2023 $876 · 2024 $586 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 4 | $89 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Exact Sciences Corporation | 3 | $43 |
| PFIZER INC. | 2 | $43 |
| Boston Scientific Corporation | 1 | $42 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Corcept Therapeutics | 1 | $29 |
| Tris Pharma Inc | 1 | $14 |
Products named: Qelbree, TRELEGY ELLIPTA, Cologuard Collection Kit, PREVNAR 20, WaveWriter Alpha Prime 16, AIRSUPRA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Korlym.
Industry payments across GA — which companies pay providers there.
